Preview

PDF Pending copyright assessment - Request a copy 132Kb

The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of more than 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies.

Item Type:	Letter or Note in Journal
Keywords:	myeloid-leukemia genome, somatic mutations, breast cancer, gene, pathways, landscapes, database
Research Division:	Medical and Health Sciences
Research Group:	Oncology and Carcinogenesis
Research Field:	Cancer Genetics
Objective Division:	Health
Objective Group:	Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:	Cancer and Related Disorders
UTAS Author:	Hudson, TJ et al. (Professor Don Chalmers)
ID Code:	80901
Year Published:	2010
Web of Science® Times Cited:	989
Deposited By:	Law
Deposited On:	2012-11-15
Last Modified:	2012-11-15
Downloads:	7 View Download Statistics